查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1630951

全球 3D 細胞培養市場：市場規模、佔有率和趨勢分析（按技術、應用、最終用途、地區和細分市場，2025-2030 年）

3D Cell Culture Market Size, Share & Trends Analysis Report By Technology (Scaffold Based, Scaffold Free), By Application (Stem Cell Research & Tissue Engineering, Cancer Research), By End-use, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 140 Pages | 商品交期: 2-10個工作天內

價格

3D 細胞培養市場的成長與趨勢：

根據Grand View Research, Inc.的最新報告，全球3D細胞培養市場規模預計到2030年將達到32.1億美元，2025年至2030年期間的複合年成長率為11.72%。

這個市場受到體外測試模型的技術進步、個人化醫療的日益關注以及政府對研發的支持性法律的推動。此外，慢性病發病率的不斷上升以及細胞療法在慢性病治療中的重要性日益增加，為該行業的擴張創造了動力。

組織工程在創建 3D 培養模型方面取得了巨大進步，與傳統的 2D 細胞培養相比，該模型可以更準確地模擬體內培養基。這導致 3D 細胞培養系統在毒性測試、藥物研發和再生醫學開發的應用增加。此外，產業參與者近期推出的產品也為市場成長提供了巨大推動力。例如，2023 年 6 月，Pixelgen Technologies 推出了首個用於對細胞表面蛋白質進行 3D 空間研究的分子像素化套件。

此外，微流體、生物列印和高內涵篩檢系統等先進技術的開發正在利用這些模型的功能。這些技術可以更好地控制培養條件、細胞組織和進行高通量篩檢的能力，從而促進 3D 培養系統的利用。此外，市場相關人員之間不斷加強合作，利用生物列印和微流體技術開發培養模型，也有助於市場成長。例如，AIM Biotech 和 MatTek 於 2023 年 6 月建立合作，提供其創新的 identTX 和 organiX微流體3D 組織培養平台以及神經生物學、免疫腫瘤學和血管生物學等特定領域的完整藥物發現研究服務。

3D 培養物正在不斷地被開發用於需要體內模型來分析藥物對體細胞組織和器官的影響的研究，因為它們能夠忠實地再現器官的典型超微結構和形態。這一因素，加上各種體外應用的支架材料和結構的多種選擇，預計將增加支架的收益。最近的研究探討了多種支架的使用，包括石墨烯支架、奈米纖維、天然海洋膠原蛋白和冷凍鑄造。此外，實驗室晶片等技術在多種檢測類型的應用，包括增殖、刺激、活力、運輸、高內涵篩檢、膜片鉗和代謝活動，預計將導致對先進高效解決方案的需求不斷增加。

然而，3D 細胞模型產品缺乏一致性是預期會阻礙市場成長的主要缺點之一。此外，細胞培養變異性、標準化挑戰、規模和製造問題以及品管問題等各種因素都可能阻礙市場成長。

3D 細胞培養市場：分析概述

  • 基於鷹架的部分在 2024 年佔據了最大的收益佔有率，為 48.85%。此部分分為水凝膠、聚合物支架、微圖案表面工程微孔盤和基於奈米纖維的支架。
  • 2024 年，幹細胞研究和組織工程領域佔據市場主導地位，佔有率為 34.23%。市場分為癌症研究、幹細胞研究和組織工程、藥物開發和毒性測試等。
  • 就最終用途領域而言，生物製藥和製藥公司領域在 2024 年佔據市場主導地位，佔有率為 46.93%。市場分為生物技術和製藥公司、學術研究機構、醫院等。
  • 北美 3D 細胞培養市場佔據全球市場主導地位，到 2024 年將佔 39.09% 的佔有率。市場受到先進（2018-2030）基礎設施、新興經濟體、主要企業的存在以及他們採取的各種策略舉措的共同驅動。

目錄

第1章 分析方法及範圍

第 2 章執行摘要

第3章 市場促進因素、趨勢與範圍

  • 市場聯動展望
    • 母市場展望
    • 相關/附隨市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制分析
  • 產業分析工具
    • 產業分析：波特五力分析
    • PESTEL 分析
    • COVID-19影響分析

第 4 章 業務技術分析

  • 3D 細胞培養市場：依技術進行差異分析
  • 鷹架底座
    • 基於鷹架的市場規模、估計值和預測（2018-2030 年）
    • 水凝膠
    • 聚合物支架
    • 微圖案表面微孔盤
    • 奈米纖維支架
  • 無支架
    • 無鷹架市場規模、估計值及預測值（2018-2030）
    • 懸滴微孔盤
    • ULA 塗層球狀微孔盤
    • 磁浮
  • 生物反應器
    • 生物反應器市場規模、估計值和預測（2018-2030）
  • 微流體
    • 微流體市場規模、估計值與預測（2018-2030 年）
  • 生物列印
    • 生物列印市場規模、估計值和預測（2018-2030 年）

第 5 章 按應用程式進行的業務分析

  • 3D 細胞培養市場：依應用進行的變化分析
  • 癌症研究
    • 癌症研究市場規模、估計值和預測（2018-2030 年）
  • 幹細胞研究與組織工程
    • 幹細胞研究和組織工程市場規模、估計值和預測（2018-2030 年）
  • 藥物開發和毒性測試
    • 藥物開發和毒性測試市場規模、估計值和預測（2018-2030 年）
  • 其他
    • 其他城市市場規模估計值及預測（2018-2030 年）

第6章 最終用途業務分析

  • 3D 細胞培養市場：依最終用途進行的變化分析
  • 生物技術和製藥公司
    • 生物技術和製藥公司市場規模、估計值和預測（2018-2030 年）
  • 學術研究所
    • 學術研究機構市場規模、估計值與預測（2018-2030 年）
  • 醫院
    • 醫院市場規模、估計值和預測（2018-2030 年）
  • 其他
    • 其他市場規模、估計值和預測（2018-2030 年）

第7章 區域經營分析

  • 3D 細胞培養市場：區域佔有率（2024 年和 2030 年）
  • 北美洲
    • 北美 3D 細胞培養市場（2018-2030 年）
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 歐洲 3D 細胞培養市場（2018-2030 年）
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 亞太地區 3D 細胞培養市場（2018-2030 年）
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 泰國
    • 韓國
  • 拉丁美洲
    • 拉丁美洲 3D 細胞培養市場（2018-2030 年）
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 中東和非洲 3D 細胞培養市場（2018-2030 年）
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第8章 競爭格局

  • 公司分類
  • 戰略地圖
  • 企業市場分析（2024）
  • 公司簡介/上市公司
    • Thermo Fisher Scientific, Inc
    • Merck KGaA
    • PromoCell GmbH
    • Lonza
    • Corning Incorporated
    • Avantor, Inc.
    • Tecan Trading AG
    • REPROCELL Inc.
    • CN Bio Innovations Ltd.
    • Lena Biosciences
Product Code: GVR-1-68038-091-0

3D Cell Culture Market Growth & Trends:

The global 3D cell culture market size is expected to reach USD 3.21 billion by 2030, registering a CAGR of 11.72% from 2025 to 2030, according to a new report by Grand View Research, Inc. The market is driven by technological advancements in in-vitro testing models, a rising focus on personalized medicine, and supportive government legislation for R&D. Moreover, the increasing prevalence of chronic disorders, and the growing significance of cell therapies in their treatment have created momentum for industry expansion.

Tissue engineering has made significant developments in creating 3D culture models that mimic the in-vivo culture media more precisely than the conventional 2D cell cultures. This resulted in increased utilization of 3D cell culture systems for toxicity testing, drug discovery, and regenerative medicine development. Also, recent product launches from industry players have supported market growth to a significant extent. For instance, in June 2023, Pixelgen Technologies launched its first molecular pixelation kit for 3D spatial study of proteins present on cell surface.

In addition, the development of advanced technologies like microfluidics, bioprinting, and high-content screening systems, has leveraged the capabilities of these models. These technologies allow excellent control over culture conditions, cell organization, and the capability to perform high-efficiency screening, thereby fueling the utilization of 3D culture systems. Moreover, increased collaboration between market players to utilize bioprinting and microfluidics techniques in developing culture models has propelled market growth. For instance, in June 2023, AIM Biotech and MatTek partnered together to offer innovative idenTX and organiX microfluidic 3D tissue culture platforms along with complete drug discovery research services in specific areas of neurobiology, immune-oncology, and vascular biology.

3D cultures can closely replicate the typical microarchitecture and morphology of organs and hence are continuously developed for studies that require in vivo models to analyze the effect of a drug over body tissues and organs. This factor, coupled with the availability of several choices in terms of the material and structure of the scaffold for a variety of in-vitro applications, is anticipated to boost revenue generation for scaffolds. Recent research has explored the use of a broad range of scaffolds, such as graphene scaffolds, nanofibers, natural marine collagen, freeze-casting, and others. In addition, emerging applications of techniques such as lab-on-a-chip in several assay types, including proliferation, stimulation, viability, transport, high content screening, patch clamping, and metabolic activity are anticipated to lead to an increase in demand for advanced and efficient solutions.

However, the lack of consistency in 3D cell model products is one of the major drawbacks that is expected to hinder the growth of the market. Moreover, various factors such as variability in cell culture, standardized challenges, scale & manufacturing issues, and quality control issues might hamper the market growth.

3D Cell Culture Market Report Highlights:

  • The scaffold-based segment held the largest revenue share of 48.85% in 2024. The segment is divided into hydrogels, polymeric scaffolds, micropatterned surfaced microplates, and nanofiber-based scaffolds.
  • The stem cell research & tissue engineering segment dominated the market with a share of 34.23% in 2024. The market is segmented into cancer research, stem cell research & tissue engineering, drug development & toxicity testing, and others.
  • In the end-use segment, the biopharmaceutical & pharmaceutical companies segment dominated the market with a share of 46.93% in 2024. The market is segmented into biotechnology & pharmaceutical companies, academic & research institutes, hospitals, and others.
  • North America 3D cell culture market dominated the global market and accounted for 39.09% share in 2024. The market is collectively driven by the presence of advanced healthcare infrastructure, developed economies, the presence of key players, and various strategic initiatives undertaken by them.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
    • 1.1.1. Technology Segment
    • 1.1.2. Application Segment
    • 1.1.3. End Use Segment
  • 1.2. Regional Scope
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information or Data Analysis:
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Validation
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Increasing demand for organ transplantation & tissue engineering
      • 3.2.1.2. Technological advancements in scaffold free technology
      • 3.2.1.3. Rise in investments and R&D funding for cell-based research
      • 3.2.1.4. Increasing focus on developing alternative to animal testing
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. High cost associated with implementation
      • 3.2.2.2. Lack of compatibility and consistency
  • 3.3. Industry Analysis Tools
    • 3.3.1. Porter's Five Forces Analysis
    • 3.3.2. PESTEL Analysis
    • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Technology Business Analysis

  • 4.1. 3D Cell Culture Market: Technology Movement Analysis
  • 4.2. Scaffold Based
    • 4.2.1. Scaffold based market estimates and forecasts, 2018 - 2030 (USD Million)
    • 4.2.2. Hydrogels
      • 4.2.2.1. Hydrogels market estimates and forecasts, 2018 - 2030 (USD Million)
    • 4.2.3. Polymeric Scaffolds
      • 4.2.3.1. Polymeric scaffolds market estimates and forecasts, 2018 - 2030 (USD Million)
    • 4.2.4. Micropatterned Surface Microplates
      • 4.2.4.1. Micropatterned surface microplates market estimates and forecasts, 2018 - 2030 (USD Million)
    • 4.2.5. Nanofiber Based Scaffolds
      • 4.2.5.1. Nanofiber based scaffolds market estimates and forecasts, 2018 - 2030 (USD Million)
  • 4.3. Scaffold Free
    • 4.3.1. Scaffold free market estimates and forecasts, 2018 - 2030 (USD Million)
    • 4.3.2. Hanging Drop Microplates
      • 4.3.2.1. Hanging drop microplates market estimates and forecasts, 2018 - 2030 (USD Million)
    • 4.3.3. Spheroid Microplates with ULA coating
      • 4.3.3.1. Spheroid microplates with ULA coating market estimates and forecasts, 2018 - 2030 (USD Million)
    • 4.3.4. Magnetic Levitation
      • 4.3.4.1. Magnetic levitation market estimates and forecasts, 2018 - 2030 (USD Million)
  • 4.4. Bioreactors
    • 4.4.1. Bioreactors market estimates and forecasts, 2018 - 2030 (USD Million)
  • 4.5. Microfluidics
    • 4.5.1. Microfluidics market estimates and forecasts, 2018 - 2030 (USD Million)
  • 4.6. Bioprinting
    • 4.6.1. Bioprinting market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 5. Application Business Analysis

  • 5.1. 3D Cell Culture Market: Application Movement Analysis
  • 5.2. Cancer Research
    • 5.2.1. Cancer research market estimates and forecasts, 2018 - 2030 (USD Million)
  • 5.3. Stem Cell Research & Tissue Engineering
    • 5.3.1. Stem cell research & tissue engineering market estimates and forecasts, 2018 - 2030 (USD Million)
  • 5.4. Drug Development & Toxicity Testing
    • 5.4.1. Drug development & toxicity testing market estimates and forecasts, 2018 - 2030 (USD Million)
  • 5.5. Others
    • 5.5.1. Others market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 6. End Use Business Analysis

  • 6.1. 3D Cell Culture Market: End Use Movement Analysis
  • 6.2. Biotechnology & Pharmaceutical Companies
    • 6.2.1. Biotechnology & pharmaceutical companies market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.3. Academic & Research Institutes
    • 6.3.1. Academic & research institutes market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.4. Hospitals
    • 6.4.1. Hospital market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.5. Others
    • 6.5.1. Others market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 7. Regional Business Analysis

  • 7.1. 3D Cell Culture Share By Region, 2024 & 2030
  • 7.2. North America
    • 7.2.1. North America 3D Cell Culture, 2018 - 2030 (USD Million)
    • 7.2.2. U.S.
      • 7.2.2.1. Key Country Dynamics
      • 7.2.2.2. Competitive Scenario
      • 7.2.2.3. Target Disease Prevalence
      • 7.2.2.4. U.S. 3D Cell Culture, 2018 - 2030 (USD Million)
    • 7.2.3. Canada
      • 7.2.3.1. Key Country Dynamics
      • 7.2.3.2. Competitive Scenario
      • 7.2.3.3. Target Disease Prevalence
      • 7.2.3.4. Canada 3D Cell Culture, 2018 - 2030 (USD Million)
    • 7.2.4. Mexico
      • 7.2.4.1. Key Country Dynamics
      • 7.2.4.2. Competitive Scenario
      • 7.2.4.3. Target Disease Prevalence
      • 7.2.4.4. Mexico 3D Cell Culture, 2018 - 2030 (USD Million)
      • 7.2.4.5.
  • 7.3. Europe
    • 7.3.1. Europe 3D Cell Culture, 2018 - 2030 (USD Million)
    • 7.3.2. UK
      • 7.3.2.1. Key Country Dynamics
      • 7.3.2.2. Competitive Scenario
      • 7.3.2.3. Target Disease Prevalence
      • 7.3.2.4. UK 3D Cell Culture, 2018 - 2030 (USD Million)
    • 7.3.3. Germany
      • 7.3.3.1. Key Country Dynamics
      • 7.3.3.2. Competitive Scenario
      • 7.3.3.3. Target Disease Prevalence
      • 7.3.3.4. Germany 3D Cell Culture, 2018 - 2030 (USD Million)
    • 7.3.4. France
      • 7.3.4.1. Key Country Dynamics
      • 7.3.4.2. Competitive Scenario
      • 7.3.4.3. Target Disease Prevalence
      • 7.3.4.4. France 3D Cell Culture, 2018 - 2030 (USD Million)
    • 7.3.5. Italy
      • 7.3.5.1. Key Country Dynamics
      • 7.3.5.2. Competitive Scenario
      • 7.3.5.3. Target Disease Prevalence
      • 7.3.5.4. Italy 3D Cell Culture, 2018 - 2030 (USD Million)
    • 7.3.6. Spain
      • 7.3.6.1. Key Country Dynamics
      • 7.3.6.2. Competitive Scenario
      • 7.3.6.3. Target Disease Prevalence
      • 7.3.6.4. Spain 3D Cell Culture, 2018 - 2030 (USD Million)
    • 7.3.7. Denmark
      • 7.3.7.1. Key Country Dynamics
      • 7.3.7.2. Competitive Scenario
      • 7.3.7.3. Target Disease Prevalence
      • 7.3.7.4. Denmark 3D Cell Culture, 2018 - 2030 (USD Million)
    • 7.3.8. Sweden
      • 7.3.8.1. Key Country Dynamics
      • 7.3.8.2. Competitive Scenario
      • 7.3.8.3. Target Disease Prevalence
      • 7.3.8.4. Sweden 3D Cell Culture, 2018 - 2030 (USD Million)
    • 7.3.9. Norway
      • 7.3.9.1. Key Country Dynamics
      • 7.3.9.2. Competitive Scenario
      • 7.3.9.3. Target Disease Prevalence
      • 7.3.9.4. Norway 3D Cell Culture, 2018 - 2030 (USD Million)
  • 7.4. Asia Pacific
    • 7.4.1. Asia Pacific 3D Cell Culture, 2018 - 2030 (USD Million)
    • 7.4.2. Japan
      • 7.4.2.1. Key Country Dynamics
      • 7.4.2.2. Competitive Scenario
      • 7.4.2.3. Target Disease Prevalence
      • 7.4.2.4. Japan 3D Cell Culture, 2018 - 2030 (USD Million)
    • 7.4.3. China
      • 7.4.3.1. Key Country Dynamics
      • 7.4.3.2. Competitive Scenario
      • 7.4.3.3. Target Disease Prevalence
      • 7.4.3.4. China 3D Cell Culture, 2018 - 2030 (USD Million)
    • 7.4.4. India
      • 7.4.4.1. Key Country Dynamics
      • 7.4.4.2. Competitive Scenario
      • 7.4.4.3. Target Disease Prevalence
      • 7.4.4.4. India 3D Cell Culture, 2018 - 2030 (USD Million)
    • 7.4.5. Australia
      • 7.4.5.1. Key Country Dynamics
      • 7.4.5.2. Competitive Scenario
      • 7.4.5.3. Target Disease Prevalence
      • 7.4.5.4. Australia 3D Cell Culture, 2018 - 2030 (USD Million)
    • 7.4.6. Thailand
      • 7.4.6.1. Key Country Dynamics
      • 7.4.6.2. Competitive Scenario
      • 7.4.6.3. Target Disease Prevalence
      • 7.4.6.4. Thailand 3D Cell Culture, 2018 - 2030 (USD Million)
    • 7.4.7. South Korea
      • 7.4.7.1. Key Country Dynamics
      • 7.4.7.2. Competitive Scenario
      • 7.4.7.3. Target Disease Prevalence
      • 7.4.7.4. South Korea 3D Cell Culture, 2018 - 2030 (USD Million)
  • 7.5. Latin America
    • 7.5.1. Latin America 3D Cell Culture, 2018 - 2030 (USD Million)
    • 7.5.2. Brazil
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Competitive Scenario
      • 7.5.2.3. Target Disease Prevalence
      • 7.5.2.4. Brazil 3D Cell Culture, 2018 - 2030 (USD Million)
    • 7.5.3. Argentina
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Competitive Scenario
      • 7.5.3.3. Target Disease Prevalence
      • 7.5.3.4. Argentina 3D Cell Culture, 2018 - 2030 (USD Million)
  • 7.6. MEA
    • 7.6.1. MEA 3D Cell Culture, 2018 - 2030 (USD Million)
    • 7.6.2. South Africa
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Competitive Scenario
      • 7.6.2.3. Target Disease Prevalence
      • 7.6.2.4. South Africa 3D Cell Culture, 2018 - 2030 (USD Million)
    • 7.6.3. Saudi Arabia
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Competitive Scenario
      • 7.6.3.3. Target Disease Prevalence
      • 7.6.3.4. Saudi Arabia 3D Cell Culture, 2018 - 2030 (USD Million)
    • 7.6.4. UAE
      • 7.6.4.1. Key Country Dynamics
      • 7.6.4.2. Competitive Scenario
      • 7.6.4.3. Target Disease Prevalence
      • 7.6.4.4. UAE 3D Cell Culture, 2018 - 2030 (USD Million)
    • 7.6.5. Kuwait
      • 7.6.5.1. Key Country Dynamics
      • 7.6.5.2. Competitive Scenario
      • 7.6.5.3. Target Disease Prevalence
      • 7.6.5.4. Kuwait 3D Cell Culture, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Company Categorization
  • 8.2. Strategy Mapping
  • 8.3. Company Market Position Analysis, 2024
  • 8.4. Company Profiles/Listing
    • 8.4.1. Thermo Fisher Scientific, Inc
      • 8.4.1.1. Overview
      • 8.4.1.2. Financial Performance
      • 8.4.1.3. Product Benchmarking
      • 8.4.1.4. Strategic Initiatives
    • 8.4.2. Merck KGaA
      • 8.4.2.1. Overview
      • 8.4.2.2. Financial Performance
      • 8.4.2.3. Product Benchmarking
      • 8.4.2.4. Strategic Initiatives
    • 8.4.3. PromoCell GmbH
      • 8.4.3.1. Overview
      • 8.4.3.2. Financial Performance
      • 8.4.3.3. Product Benchmarking
      • 8.4.3.4. Strategic Initiatives
    • 8.4.4. Lonza
      • 8.4.4.1. Overview
      • 8.4.4.2. Financial Performance
      • 8.4.4.3. Product Benchmarking
      • 8.4.4.4. Strategic Initiatives
    • 8.4.5. Corning Incorporated
      • 8.4.5.1. Overview
      • 8.4.5.2. Financial Performance
      • 8.4.5.3. Product Benchmarking
      • 8.4.5.4. Strategic Initiatives
    • 8.4.6. Avantor, Inc.
      • 8.4.6.1. Overview
      • 8.4.6.2. Financial Performance
      • 8.4.6.3. Product Benchmarking
      • 8.4.6.4. Strategic Initiatives
    • 8.4.7. Tecan Trading AG
      • 8.4.7.1. Overview
      • 8.4.7.2. Financial Performance
      • 8.4.7.3. Product Benchmarking
      • 8.4.7.4. Strategic Initiatives
    • 8.4.8. REPROCELL Inc.
      • 8.4.8.1. Overview
      • 8.4.8.2. Product Benchmarking
      • 8.4.8.3. Strategic Initiatives
    • 8.4.9. CN Bio Innovations Ltd.
      • 8.4.9.1. Overview
      • 8.4.9.2. Product Benchmarking
      • 8.4.9.3. Strategic Initiatives
    • 8.4.10. Lena Biosciences
      • 8.4.10.1. Overview
      • 8.4.10.2. Financial Performance
      • 8.4.10.3. Product Benchmarking
      • 8.4.10.4. Strategic Initiatives

List of Tables

  • Table 1 List of abbreviation
  • Table 2 Global 3D cell culture market, by region, 2018 - 2030 (USD Million)
  • Table 3 North America 3D cell culture market, by country, 2018 - 2030 (USD Million)
  • Table 4 North America 3D cell culture market, by technology, 2018 - 2030 (USD Million)
  • Table 5 North America 3D cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 6 North America 3D cell culture market, by end use, 2018 - 2030 (USD Million)
  • Table 7 U.S. 3D cell culture market, by technology, 2018 - 2030 (USD Million)
  • Table 8 U.S. 3D cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 9 U.S. 3D cell culture market, by end use, 2018 - 2030 (USD Million)
  • Table 10 Canada 3D cell culture market, by technology, 2018 - 2030 (USD Million)
  • Table 11 Canada 3D cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 12 Canada 3D cell culture market, by end use, 2018 - 2030 (USD Million)
  • Table 13 Mexico 3D cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 14 Mexico 3D cell culture market, by end use, 2018 - 2030 (USD Million)
  • Table 15 Mexico 3D cell culture market, by technology, 2018 - 2030 (USD Million)
  • Table 16 Europe 3D cell culture market, by country, 2018 - 2030 (USD Million)
  • Table 17 Europe 3D cell culture market, by technology, 2018 - 2030 (USD Million)
  • Table 18 Europe 3D cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 19 Europe 3D cell culture market, by end use, 2018 - 2030 (USD Million)
  • Table 20 Germany 3D cell culture market, by technology, 2018 - 2030 (USD Million)
  • Table 21 Germany 3D cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 22 Germany 3D cell culture market, by end use, 2018 - 2030 (USD Million)
  • Table 23 UK 3D cell culture market, by technology, 2018 - 2030 (USD Million)
  • Table 24 UK 3D cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 25 UK 3D cell culture market, by end use, 2018 - 2030 (USD Million)
  • Table 26 France 3D cell culture market, by technology, 2018 - 2030 (USD Million)
  • Table 27 France 3D cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 28 France 3D cell culture market, by end use, 2018 - 2030 (USD Million)
  • Table 29 Italy 3D cell culture market, by technology, 2018 - 2030 (USD Million)
  • Table 30 Italy 3D cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 31 Italy 3D cell culture market, by end use, 2018 - 2030 (USD Million)
  • Table 32 Spain 3D cell culture market, by technology, 2018 - 2030 (USD Million)
  • Table 33 Spain 3D cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 34 Spain 3D cell culture market, by end use, 2018 - 2030 (USD Million)
  • Table 35 Denmark 3D cell culture market, by technology, 2018 - 2030 (USD Million)
  • Table 36 Denmark 3D cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 37 Denmark 3D cell culture market, by end use, 2018 - 2030 (USD Million)
  • Table 38 Sweden 3D cell culture market, by technology, 2018 - 2030 (USD Million)
  • Table 39 Sweden 3D cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 40 Sweden 3D cell culture market, by end use, 2018 - 2030 (USD Million)
  • Table 41 Norway 3D cell culture market, by technology, 2018 - 2030 (USD Million)
  • Table 42 Norway 3D cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 43 Norway 3D cell culture market, by end use, 2018 - 2030 (USD Million)
  • Table 44 Asia Pacific 3D cell culture market, by country, 2018 - 2030 (USD Million)
  • Table 45 Asia Pacific 3D cell culture market, by technology, 2018 - 2030 (USD Million)
  • Table 46 Asia Pacific 3D cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 47 Asia Pacific 3D cell culture market, by end use, 2018 - 2030 (USD Million)
  • Table 48 China 3D cell culture market, by technology, 2018 - 2030 (USD Million)
  • Table 49 China 3D cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 50 China 3D cell culture market, by end use, 2018 - 2030 (USD Million)
  • Table 51 Japan 3D cell culture market, by technology, 2018 - 2030 (USD Million)
  • Table 52 Japan 3D cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 53 Japan 3D cell culture market, by end use, 2018 - 2030 (USD Million)
  • Table 54 India 3D cell culture market, by technology, 2018 - 2030 (USD Million)
  • Table 55 India 3D cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 56 India 3D cell culture market, by end use, 2018 - 2030 (USD Million)
  • Table 57 South Korea 3D cell culture market, by technology, 2018 - 2030 (USD Million)
  • Table 58 South Korea 3D cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 59 South Korea 3D cell culture market, by end use, 2018 - 2030 (USD Million)
  • Table 60 Australia 3D cell culture market, by technology, 2018 - 2030 (USD Million)
  • Table 61 Australia 3D cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 62 Australia 3D cell culture market, by end use, 2018 - 2030 (USD Million)
  • Table 63 Thailand 3D cell culture market, by technology, 2018 - 2030 (USD Million)
  • Table 64 Thailand 3D cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 65 Thailand 3D cell culture market, by end use, 2018 - 2030 (USD Million)
  • Table 66 Latin America 3D cell culture market, by country, 2018 - 2030 (USD Million)
  • Table 67 Latin America 3D cell culture market, by technology, 2018 - 2030 (USD Million)
  • Table 68 Latin America 3D cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 69 Latin America 3D cell culture market, by end use, 2018 - 2030 (USD Million)
  • Table 70 Brazil 3D cell culture market, by technology, 2018 - 2030 (USD Million)
  • Table 71 Brazil 3D cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 72 Brazil 3D cell culture market, by end use, 2018 - 2030 (USD Million)
  • Table 73 Argentina 3D cell culture market, by technology, 2018 - 2030 (USD Million)
  • Table 74 Argentina 3D cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 75 Argentina 3D cell culture market, by end use, 2018 - 2030 (USD Million)
  • Table 76 MEA 3D cell culture market, by country, 2018 - 2030 (USD Million)
  • Table 77 MEA 3D cell culture market, by technology, 2018 - 2030 (USD Million)
  • Table 78 MEA 3D cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 79 MEA 3D cell culture market, by end use, 2018 - 2030 (USD Million)
  • Table 80 South Africa 3D cell culture market, by technology, 2018 - 2030 (USD Million)
  • Table 81 South Africa 3D cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 82 South Africa 3D cell culture market, by end use, 2018 - 2030 (USD Million)
  • Table 83 Saudi Arabia 3D cell culture market, by technology, 2018 - 2030 (USD Million)
  • Table 84 Saudi Arabia 3D cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 85 Saudi Arabia 3D cell culture market, by end use, 2018 - 2030 (USD Million)
  • Table 86 UAE 3D cell culture market, by technology, 2018 - 2030 (USD Million)
  • Table 87 UAE 3D cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 88 UAE 3D cell culture market, by end use, 2018 - 2030 (USD Million)
  • Table 89 Kuwait 3D cell culture market, by technology, 2018 - 2030 (USD Million)
  • Table 90 Kuwait 3D cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 91 Kuwait 3D cell culture market, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 3D cell culture market: market outlook
  • Fig. 9 Parent market outlook
  • Fig. 10 3D cell culture market driver impact
  • Fig. 11 3D cell culture market restraint impact
  • Fig. 12 3D cell culture market: technology outlook and key takeaways
  • Fig. 13 3D cell culture market: technology movement analysis
  • Fig. 14 Scaffold based market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 15 Hydrogels market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 16 Polymeric scaffolds market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 17 Micropatterned surface microplates market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 18 Nanofiber based scaffolds market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 19 Scaffold free market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 20 Hanging drop microplates market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 21 Spheroid microplates with ULA coating market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 22 Magnetic levitation market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 23 Bioreactors market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 24 Microfluidics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 25 Bioprinting market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 26 3D cell culture market: application outlook and key takeaways
  • Fig. 27 3D cell culture market: application movement analysis
  • Fig. 28 Cancer research market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 29 Stem cell research & tissue engineering market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 30 Drug development & toxicity testing market estimates and forecasts,2018 - 2030 (USD Million)
  • Fig. 31 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 32 3D cell culture market: end use outlook and key takeaways
  • Fig. 33 3D cell culture market: end use movement analysis
  • Fig. 34 Biotechnology & pharmaceutical companies market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 Academic & research institutes market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 Hospitals market estimates and forecasts,2018 - 2030 (USD Million)
  • Fig. 37 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 38 North America 3D cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 U.S. 3D cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 Canada 3D cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 Mexico 3D cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 Europe 3D cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 UK 3D cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 Germany 3D cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 France 3D cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 Italy 3D cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 Spain 3D cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 Denmark 3D cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Sweden 3D cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 Norway 3D cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Asia Pacific 3D cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 China 3D cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 Japan 3D cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 India 3D cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 Thailand 3D cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 South Korea 3D cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 Australia 3D cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 Latin America 3D cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 59 Brazil 3D cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 60 Argentina 3D cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 61 Middle East and Africa 3D cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 62 South Africa 3D cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 63 Saudi Arabia 3D cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 64 UAE 3D cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 65 Kuwait 3D cell culture market estimates and forecasts, 2018 - 2030 (USD Million)